Pict.: Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria. A new UV light method for cleaning hospital rooms could help stop the spread of dangerous bacteria, and in turn, save lives. Texas A&M Health Science CenterUV light robot to clean hospital rooms could help stop spread of ‘superbugs’

 

BRYAN, Texas, USA (April 14, 2015) – Can a robot clean a hospital room just as well as a person? According to new research out of the Texas A&M Health Science Center College of Medicine, that is indeed the case. Chetan Jinadatha, M.D., M.P.H., assistant professor at the Texas A&M College of Medicine and chief of infectious diseases at the Central Texas Veterans Health Care System in Temple, is studying the effectiveness of a germ-zapping robot to clean hospital rooms, which could hold the key to preventing the spread of "superbugs" – in turn, saving countless dollars and, most importantly, lives. 


Keeping hospital rooms clean is important to prevent the spread of infections from one patient to another. Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), which can be difficult to treat, and in some cases, fatal.

 

"A typical 100-bed hospital sees about 10-20 hospital-acquired infections a year," Jinadatha says. "Our goal is to get to zero infections."

 

In addition to the human toll, hospitals now have a financial reason to reduce hospital-acquired infections: beginning in 2017, the federal government will dramatically reduce Medicare payments to hospitals that exceed incidences of certain conditions, such as hospital-acquired infections.

 

Since the current method of cleaning hospital rooms relies heavily on housekeeping staff, who often have a high turnover rate, Jinadatha has focused his research on using technology to prevent hospital-acquired infections. In particular, he is studying the effectiveness of a pulsed xenon ultraviolet (UV) light system that was developed in Texas. Jinadatha has been among the first to study the system since it was introduced in 2011.

 

The device – which Jinadatha admits bears a striking resemblance to the fictional robot in Star Wars known as R2-D2 – has a large saucer-shaped head on top of a column that rises up to reveal a bulb filled with xenon gas. When the system is switched on, high-voltage electricity passes through the bulb and releases a spectrum of UV light that binds to the DNA of organisms and kills them.

Werbung

 

Last year, Jinadatha published a study that compared the effectiveness of manual disinfection alone to manual disinfection plus the use of UV light. This study found that manual cleaning plus UV light killed more than 90 percent of the bacteria, compared to 70 percent with manual cleaning alone. Of particular note was the fact that manual disinfection plus UV light killed 99 percent of the bacteria that cause MRSA.

 

Jinadatha’s latest study, which was published earlier this year in the American Journal of Infection Control, looked at the effectiveness of UV light disinfection by itself. This study found that in just 12 minutes, the UV light system cut the amount bacteria in the room by about 70 percent – roughly the same level of effectiveness as manual disinfection.

 

Jinadatha stresses that he would never recommend that a hospital use the UV light system by itself, but he believes it does have value as a "safety net" to kill bacteria that traditional cleaning may miss. Currently the system is being used in 40 VA hospitals across the country and about 200 private hospitals. He predicts it will eventually become standard equipment at all hospitals.

 

"There is no one thing that will take away the problem of hospital-acquired infections, but we are slowly chipping away at it," he says.

 

 

Pict.: Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria. A new UV light method for cleaning hospital rooms could help stop the spread of dangerous bacteria, and in turn, save lives. Texas A&M Health Science Center

 


Texas A&M University, 14.04.2015 (tB).

MEDICAL NEWS

Monoclonal antibody therapy for COVID-19 safe, effective for transplant patients
Having trouble falling asleep predicts cognitive impairment in later life
SARS-CoV-2 detectable — though likely not transmissible — on hospital…
Waking just one hour earlier cuts depression risk by double…
Moving one step closer to personalized anesthesia

SCHMERZ PAINCARE

Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern
Wenn Schmerzen nach einer OP chronisch werden

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…

ONKOLOGIE

Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung
Risikobasiertes Brustkrebs-Screening kosteneffektiv
Krebs – eine unterschätzte finanzielle Herausforderung

MULTIPLE SKLEROSE

Goldstandard für Versorgung bei Multipler Sklerose
Patienteninformationen zu Interferon-beta-Präparaten
Zulassung des S1P Modulators Ponesimod zur Behandlung von erwachsenen Patienten…
Neue S2k-Leitlinie für Diagnostik und Therapie der Multiplen Sklerose
Krankheitsbezogenes Kompetenznetz Multiple Sklerose: Stellungnahme zu SARS CoV 2 Impfdaten…

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung